AA
About
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 36 investors are based in Lund, Skane Lan, Sweden.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Lund, Sweden
Contact Information
linkedin.com/in/••••••••
Find more investors like Abliva
Search Investors